
Vaxxers
Sarah Gilbert and Dr. Catherine Green
What's inside?
Dive into the groundbreaking journey of creating the life-saving COVID-19 vaccine, narrated by the very scientists who made it possible.
You'll learn
Key points
01The Genesis of a Revolution
In the quiet town of Kettering, Northamptonshire, a young Sarah Gilbert found her curiosity piqued by the natural world, a fascination inherited from her father. This early interest would serve as the foundation for a career that would change the course of history. Meanwhile, in the bustling city of London, Catherine Green was captivated by the complexities of the human body, a fascination that would lead her to the forefront of clinical virology. These two seemingly disparate paths would eventually converge in a momentous collaboration that would alter the trajectory of a global pandemic. Gilbert's academic journey led her to the University of East Anglia, where she pursued a degree in Biological Sciences, and later to the University of Hull for a PhD in Biochemistry. Her research focused on the development of influenza vaccines, a field that would prove instrumental in her future endeavors. Gilbert's work in virology took a significant turn when she joined the Jenner Institute at the University of Oxford as a Professor of Vaccinology. Here, she led the team that developed the universal flu vaccine, a testament to her expertise and dedication to public health. Parallel to Gilbert's journey, Green was carving her own path in the medical field. After studying medicine at the University of Oxford, she specialized in clinical virology, focusing on the study of HIV and the development of antiretroviral therapy. Her career trajectory led her to become the head of the Nuffield Department of Medicine's Clinical Biomanufacturing Facility at the University of Oxford. Here, her team was responsible for producing early clinical trial materials, including vaccines for diseases like MERS and Ebola, showcasing her leadership and commitment to combating global health crises. The COVID-19 pandemic served as the catalyst for the convergence of these two remarkable journeys. Recognizing the urgent need for a vaccine, Gilbert and Green collaborated to develop the Oxford-AstraZeneca vaccine. Their combined expertise in virology and immunology, coupled with their shared commitment to public health, made this collaboration a groundbreaking moment in scientific history. The genesis of this revolution was rooted in their individual journeys, marked by relentless curiosity, rigorous academic pursuit, and unwavering dedication to public health. Their collaboration not only resulted in a vaccine that has been instrumental in curbing the pandemic but also set a precedent for future scientific collaborations. The story of Gilbert and Green serves as a testament to the power of interdisciplinary collaboration and the profound impact it can have on global health. Their work will undoubtedly continue to inspire future generations of scientists and serve as a beacon of hope in times of crisis.
02The Confluence of Minds
In the annals of scientific history, the collaboration between Sarah Gilbert and Dr. Catherine Green stands as a testament to the power of shared vision and relentless pursuit of a common goal. Their journey, marked by numerous challenges and triumphs, offers a compelling narrative of resilience, determination, and the transformative power of science. At the heart of their professional relationship was a shared vision for a healthier world. Both Gilbert and Green believed in the potential of science to combat diseases and improve human life. This shared vision served as the bedrock of their collaboration, shaping their approach to research and driving their relentless pursuit of a solution. The formation of their team was a critical first step in their journey. Assembling a team of like-minded individuals who shared their vision and passion for scientific research was no small feat. The process required a rigorous selection process, aimed at identifying individuals who were not only skilled in their respective fields but also willing to work tirelessly towards their shared goal. The result was a team of dedicated scientists and researchers, united by a common purpose and committed to the pursuit of scientific breakthroughs. Securing funding for their research was another significant hurdle they faced. Despite the potential of their work, convincing potential investors of its viability proved to be a daunting task. They faced numerous rejections, but their resolve remained unshaken. Their persistence eventually paid off, securing the necessary funding to propel their research forward. The development of their vaccine was a journey fraught with difficulties. Navigating through a myriad of regulatory hurdles and meeting stringent safety standards was a complex and challenging process. There were moments when their research hit a dead end, forcing them to reassess their approach and devise new strategies. Yet, they remained undeterred, their commitment to their goal unwavering. The successful completion of the first phase of clinical trials marked a significant turning point in their collaboration. This milestone validated their hard work and bolstered their confidence, paving the way for the subsequent phases of the trial. The story of Gilbert and Green is a powerful reminder of the potential of collaboration and the power of a shared vision. Despite the numerous challenges they faced, their unwavering commitment, the strength of their team, and their shared vision propelled them forward. Their journey serves as an inspiration, a testament to the transformative power of science when driven by a shared vision and relentless pursuit of a common goal.

Continue reading with LeapAhead app
Full summary is waiting for you in the app
03The Invisible Enemy
04The Race Against Time
05The Triumph of Science
06The Aftermath and Beyond
07Conclusion
About Sarah Gilbert and Dr. Catherine Green
Sarah Gilbert is a British vaccinologist and Professor of Vaccinology at the University of Oxford. Dr. Catherine Green is a British scientist, also at the University of Oxford, specializing in viral immunology. They co-developed the Oxford-AstraZeneca COVID-19 vaccine.